MEDIKAL
ActiveMEDIKAL has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €36k and a net result of €34k. Its solvency ranks better than 48% of 16511 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
87
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes
Profitability100
Solvency86
Growth-
Track record67
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3k at 30 days acceptable
Liquidity ample (current ratio 1.53; short-term debt: 38.7% and cash: 22.9% of total assets), and 39.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
60.6%
Return on assets
57%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filingDeviation from the deadline
2025
28 d late
← before the deadline
after the deadline →
Financials · fiscal year 2025, micro schema
Equity
€36k
Total assets
€60k
Net result
€34k
Working capital
€12k
Turnover and EBIT margin not published: the micro schema does not require them.
Balance-sheet composition
Assets €60k
Fixed assets
€25k
Current assets
€36k
Equity and liabilities €60k
Equity
€36k
Debt
€24k
Debt finances 39.4% of the balance-sheet total.
Key figures and ratios
EBITDA
€51k
Cash flow
€39k
Solvency
60.6%
Current ratio
1.53
Quick ratio
1.53
Debt / equity
0.65
ROE
94.1%
ROA
57.0%
Interest coverage
24.40
Debt
€24k
Debt ≤ 1 year
€23k
Income taxes
€10k
Filed annual accounts
As filed with the NBB · 2025
Balance sheet
Code2025
Assets
Total assets20/58€60k
Fixed assets21/28€25k
Tangible fixed assets22/27€25k
Furniture and vehicles24€25k
Current assets29/58€36k
Amounts receivable within one year40/41€18k
Trade receivables40€18k
Cash at bank and in hand54/58€14k
Deferred charges and accrued income490/1€4k
Equity and liabilities
Total equity and liabilities10/49€60k
Equity10/15€36k
Contributions10/11€3k
Profit (loss) carried forward14€33k
Amounts payable17/49€24k
Amounts payable within one year42/48€23k
Trade debts44€890
Suppliers440/4€890
Taxes, remuneration and social security45€21k
Taxes450/3€15k
Remuneration and social security454/9€6k
Other amounts payable47/48€2k
Accrued charges and deferred income492/3€370
Income statement
Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k
Other operating charges640/8€478
Gross operating margin9900€52k
Operating profit (loss)9901€46k
Financial charges65/66B€2k
Recurring financial charges65€2k
Profit (loss) for the period before taxes9903€44k
Income taxes67/77€10k
Profit (loss) for the period9904€34k
Profit (loss) for the period to be appropriated9905€34k
Appropriation of the result
Profit (loss) to be appropriated9906€34k
Profit to be distributed694/7€833
Return on contributions (dividend)694€833
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
28-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 28 days late
NBB filing
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Grez-Doiceau · 1 establishment unit since 2024
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Sentier Cinq Bonniers 71390 Grez-Doiceau1 establishment unit
MEDIKAL
since 20242.365.349.453
Similar companies · same sector, comparable size
IVH Consulting
BE 0803.633.320
Gent · Eq €37k
Docteur Marc DE SMEDT
BE 0882.064.352
Fléron · Eq €37k
ENDOCRINOLOGIE AZ MARIA MIDDELARES
BE 0757.534.366
Gent · Eq €37k
Medical Consulting HD
BE 0801.221.087
Koksijde · Eq €37k
Barbance Océane
BE 1019.904.223
Nivelles · Eq €37k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 4,426 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-10-2024
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filing
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.